2026 NPPES data Colon & Rectal Surgery Physician NPI 1780689232 MD
Verify on CMS →

DAVID ZEBLEY, MD

Colon & Rectal Surgery Physician in ABINGTON, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
92
Medicare Part D claims · 64 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.625/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$330.82
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DAVID ZEBLEY, MD reported a CMS MIPS final score of 93.625/100 — above the 83.1 national average — and filed 92 Medicare Part D claims in 2023.

93.625/100
MIPS score · +11 vs avg
92
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DAVID ZEBLEY, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DAVID ZEBLEY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DAVID ZEBLEY, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/20/2005

NPI 1780689232

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,608 US NPIs in this specialty

Medicare Part D claims

92 53% vs specialty avg

2023 prescription claims

Specialty avg: 196

MIPS final score

93.625/100 10.525000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Colon & Rectal Surgery Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Colon & Rectal Surgery Physician share within Pennsylvania

1. Colon & Rectal Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Colon & Rectal Surgery Physician share within Pennsylvania

Medicare quality performance — MIPS

DAVID ZEBLEY, MD's 2023 MIPS final score plotted against the Colon & Rectal Surgery Physician national average

High performer (top quartile)
MIPS Final Score
93.625/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Colon & Rectal Surgery Physician) — 93.625/100 vs national avg 83.1

0%100%National avg83%93.6%
MIPS final score (Colon & Rectal Surgery Physician) — 93.625/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID ZEBLEY, MD appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding MD credentials at 1235 OLD YORK RD, ABINGTON, PA, 19001, with a listed phone of (215) 517-1250. NPI 1780689232 was issued on 06/20/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZEBLEY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 92 prescription claims written by this provider, covering 64 Medicare beneficiaries and totaling roughly $5K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.625/100 for the 2023 performance year (Quality 87.25), compared with the national average of 83.1.

Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1235 OLD YORK RD
ABINGTON, PA 19001

Provider Details

NPI 1780689232
Specialty Colon & Rectal Surgery Physician
Credentials MD
Gender Male
NPI Issued 06/20/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.625
Final Score
Avg: 83.1
87.25
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where DAVID ZEBLEY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COLON AND RECTAL ASSOCIATES, LTD
ABINGTON, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID ZEBLEY, MD. Source: openpaymentsdata.cms.gov.

Total received

$331

Largest payer

Ethicon US, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to DAVID ZEBLEY, MD. To verify DAVID ZEBLEY, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

DAVID ZEBLEY, MD — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 92 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

92
Total Claims
$5K
Total Drug Cost
64
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
99
Total Day Supply
1,114
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$2K
Generic Drug Cost
$2K
Antibiotic Claims
46

Patient Demographics

Average Patient Age
76.1 years
Avg HCC Risk Score
1.45
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Metronidazole
40
Mesalamine Er
Mesalamine
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How DAVID ZEBLEY, MD fits within the Colon & Rectal Surgery Physician landscape nationally.

1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider

DAVID ZEBLEY, MD's 92 claims are below the specialty average of 196.

Nearby Colon & Rectal Surgery Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as ZEBLEY.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID ZEBLEY, MD's specialty?
DAVID ZEBLEY, MD specializes in Colon & Rectal Surgery Physician and practices in ABINGTON, Pennsylvania. Credentials: MD.
How much does DAVID ZEBLEY, MD prescribe under Medicare Part D?
In 2023, DAVID ZEBLEY, MD wrote 92 Medicare Part D claims totaling $5K in drug costs for 64 beneficiaries.
What is DAVID ZEBLEY, MD's Medicare quality score?
DAVID ZEBLEY, MD has a CMS MIPS Final Score of 93.625/100 (Quality: 87.25). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DAVID ZEBLEY, MD located?
DAVID ZEBLEY, MD is located at 1235 OLD YORK RD, ABINGTON, PA, 19001. Phone: (215) 517-1250.
What is DAVID ZEBLEY, MD's NPI number?
DAVID ZEBLEY, MD's National Provider Identifier (NPI) is 1780689232, issued on 06/20/2005.
Does DAVID ZEBLEY, MD prescribe more brand-name or generic drugs?
DAVID ZEBLEY, MD's prescribing is 23% brand-name and 77% generic drugs by claim count, with $2K in brand drug costs.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does DAVID ZEBLEY, MD prescribe most often?
Based on 2023 Medicare Part D data, DAVID ZEBLEY, MD's most frequently prescribed drugs include Metronidazole, Mesalamine Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID ZEBLEY, MD accept Medicare?
DAVID ZEBLEY, MD appears in CMS Medicare data with 92 Part D claims and 64 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID ZEBLEY, MD's credentials?
DAVID ZEBLEY, MD's NPI is 1780689232 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology